Transmedics Group Inc’s recent filing unveils that its Chief Commercial Officer Khayal Tamer I unloaded Company’s shares for reported $86694.0 on Jan 07 ’25. In the deal valued at $80.05 per share,1,083 shares were sold. As a result of this transaction, Khayal Tamer I now holds 20,843 shares worth roughly $1.61 million.
Then, Khayal Tamer I sold 1,084 shares, generating $93,658 in total proceeds. Upon selling the shares at $86.40, the Chief Commercial Officer now owns 20,843 shares.
Before that, Khayal Tamer I sold 1,458 shares. Transmedics Group Inc shares valued at $131,278 were divested by the Chief Commercial Officer at a price of $90.04 per share. As a result of the transaction, Khayal Tamer I now holds 20,843 shares, worth roughly $1.61 million.
JP Morgan downgraded its Transmedics Group Inc [TMDX] rating to a Neutral from a an Overweight in a research note published on December 17, 2024; the price target was decreased to $75 from $116. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Hold”. Oppenheimer also remained covering TMDX and reiterated its “an Outperform” recommendation on October 29, 2024. Needham maintained its rating on October 29, 2024. It rated TMDX as “a Buy”.
Price Performance Review of TMDX
On Friday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock jump 7.19% to $77.12. Over the last five days, the stock has gained 6.84%. Transmedics Group Inc shares have risen nearly 23.69% since the year began. Nevertheless, the stocks have fallen -11.35% over the past one year. While a 52-week high of $177.37 was reached on 01/07/25, a 52-week low of $55.00 was recorded on 01/21/25. SMA at 50 days reached $66.93, while 200 days put it at $116.69.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 73.17, which if violated will result in even more drops to 69.23. On the upside, there is a resistance level at 79.40. A further resistance level may holdings at 81.69. The Relative Strength Index (RSI) on the 14-day chart is 59.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.77, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 21.46%. Stochastics %K at 66.11% indicates the stock is a holding.
The most recent change occurred on September 24, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $200 price target.
